Dermatology Devices Market Share Grow at 12.7% CAGR By 2027- Leading Key Players are Alma Lasers, Ltd. (a subsidiary of Sisram Medical Ltd.) (Israel), Cutera, Inc. (US), Cynosure Inc. (US), El.En. S.p.A. (Italy)

The Dermatology Devices Market is projected to reach USD 11.3 billion by 2027 from USD 6.2 billion in 2022, at a CAGR of 12.7% during the forecasted period. The growth in this market is expected to be driven by the rising incidence of skin disorders, increasing awareness of aesthetic procedures, and technological advancements. However, the stringent regulatory policies for medical devices may hinder the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=154&utm_source=Openpr3Nov&utm_medium=referral

The lasers are accounted to hold the largest share of the dermatology devices market, by type in 2021.

Based on type, the dermatology treatment market is segmented into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices, and cryotherapy devices. In 2021, the lasers segment accounted for the largest share of the dermatology treatment devices market. The large share of this segment can be attributed to the rising incidence of skin disorders, technological advancements, and the increasing preference for minimally invasive procedures.

The hair removal treatment is accounted to hold the largest share of the dermatology treatment devices market, by application in 2021.

Based on application, the dermatology treatment devices market is segmented into hair removal; skin rejuvenation; acne, psoriasis, and tattoo removal; wrinkle removal and skin resurfacing; body contouring and fat removal; vascular and pigmented lesion removal; warts, skin tags, and weight management; and other applications. the hair removal segment accounted for the largest share of the dermatology treatment devices market. The large share of this segment can primarily be attributed to the increasing number of hair removal procedure.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=154&utm_source=Openpr3Nov&utm_medium=referral

North America accounted for the largest share of the dermatology devices market in 2021.

Based on region, the dermatology device market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the market. The large share of this regional segment can be attributed to factors such as the rising incidence of skin diseases, increased awareness about aesthetic procedures, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region.

The major players operating in this dermatology devices market are Alma Lasers, Ltd. (a subsidiary of Sisram Medical Ltd.) (Israel), Cutera, Inc. (US), Cynosure Inc. (US), El.En. S.p.A. (Italy), Lumenis, Ltd. (a subsidiary of Boston Scientific) (Israel), Solta Medical (a subsidiary of Bausch Health Companies Inc.) (US), Bruker Corporation (US), Carl Zeiss (Germany), Candela Corporation (US), Genesis Biosystems, Inc. (US), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics Ltd. (UK), PhotoMedex, Inc. (US), Leica Microsystems (a subsidiary of Danaher Corporation) (US), Olympus Corporation (Japan), FotoFinder Systems GmbH (Germany), Canfield Scientific, Inc. (US), Beijing Toplaser Technology Co., Ltd. (China), DermLite (US), Syneron Medical Ltd. (a part of Apax Partners) (US), Aerolase (US), and Bovie (a subsidiary of Symmetry Surgical) (US).

Key developments

In 2022, Cynosure, Inc. collaborated with Clayton, Dubilier & Rice and announced a new investment of USD 60 million from lead investor Clayton, Dubilier & Rice

In 2021, Lumenis entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific. The acquisition of Lumenis Surgical (including its robust product portfolio, global team, and the Israeli surgical laser center of excellence) represents a major milestone for the Lumenis team and will enable Boston Scientific to enhance the execution of its urology strategy.

In 2022, Candela collaborated with The Vascular Birthmarks Foundation, Dr. Giacomo Colletti, Laserplast, this collaboration enabled more than 30 pre-qualified patients from 13 countries to receive free laser treatments in Milan

In 2022, Canfield Scientific, Inc. acquired Medici Medical s.r.l. to create Canfield Scientific s.r.l., open a state-of-the-art facility near Modena, and launch a medical dermatology education program.

In 2021, Alma launched Alma PrimeX, a non-invasive platform for body contouring and skin tightening.

In 2021, Alma launched Alma Hybrid, which exclusively combines 3 powerful energy sources to deliver effective results.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=154&utm_source=Openpr3Nov&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.